Timothy Walsh - Curriculum Vitae#
Univerity of Oxford
Ineos Institute at Oxford
- Active collaborations in China, Vietnam, Thailand, Laos, Nigeria, Niger, Pakistan, Bangladesh, Brazil, Kenya, Sierra Leone, Mozambique, Rwanda, Ethiopia, and Egypt
- Honorary Chair at Chinese Agricultural University, Beijing
- Director of BALANCE (clinical and economic burden of AMR in LMICs)
- Director of BARNARDS (neonatal sepsis and mortality)
Advisory boards
- Honorary Chair at Chinese Agricultural University, Beijing
- AMR Advisor to the United Nations
- International Engagement Officer for British Society of Antimicrobial Chemotherapy
- Director of BARNARDS (Burden of Antimicrobial Resistance in Neonates in Developing Societies) AMR infections in neonates funded by Gates Foundation)
- Senior Consultant to the Fleming Fund (Mott MacDonald/DoH)[2017-2023]]
- Advisor to the Chinese CDC
- Advisor to the Chinese DoH and DoA
- Advisor to the ECDC
- Advisor and Collaborator to Médecins Sans Frontières
- Co-ordinator and presenter of European workshops “HEAR”
- Committee member of Children's Antibiotic Resistant infections in Low-Income countries: an international cohort study (BIRDY)
Selected Research Grant Income
- 2021 - 2026 INEOS Institute of Antimicrobial Research, Oxford. I am Biology lead and Co-director of the IOI (£100M)
- 2020 - 2023 Wellcome Trust. COVID and AMR (£1.0M)
- 2019 - 2023 MRC-NSFC. DXC (DETER-XDR-China)-HUB. £2.9M (MR/S013768/1)
- 2018 - 2022 BBSRC/MOST/NFSC. CUT-SEC (China/UK/Thailand Program on Poultry Biosafety for Salmonella, E. coli and Campylobacter (CUT-SEC). £2.4M (BB/R012776/1)
- 2016 - 2022 NSFC/MRC – DETER-XDR-CHINA (£1.3M)
